Fibroid Relief, the FUS Foundation’s patient support initiative, has launched a renovated web site to improve its ability to educate women about MR-guided focused ultrasound as a non-invasive treatment option for uterine fibroids.
In October of 2008, the Foundation launched Fibroid Relief to fill an information void for patients with uterine fibroids. Through public events and its website, this initiative has become a vital and respected source of information about uterine fibroid treatment options, including MR-guided focused ultrasound.
Denise Nebgen, MD, PhD
The revamped web site presents Fibroid Relief’s educational material in a better organized format and features a new educational video series with the expectation that these changes will make the important information even more accessible. MRgFUS is given special emphasis on the site with a large section on the different aspects of the procedure, imonies from women who have had the treatment, and a strong prominence in the video series.
“We’ve continued to revise and refine the information Fibroid Relief delivers to ensure we’re providing patients comprehensive information to aid them in making the best decision about their own care,” says Fibroid Relief Founder Joy Polefrone, Ph.D. “I’m delighted to see the launch of the revamped site, as it’s a substantial advancement in the types and depth of information on Fibroid Relief’s site, and I hope it will help us continue to achieve the important mission of educating women about their full range of treatment options.”
The new video series represents the biggest move forward for the web site. The series includes nine videos, eight of which are hosted by three physicians from the Fibroid Relief Advisory Board, who generously gave of their time to help women better understand their options. John Fischer, MD, St. Luke’s Episcopal Hospital; Denise Nebgen, MD, PhD, The Methodist Hospital; and Robert Zurawin, MD, Baylor College of Medicine, present material on topics including MRgFUS, Surgical Options, Hormonal Treatment Options and more. In order to include a patient perspective in the series, the ninth video features a Fibroid Relief patient advocate talking about her successful experience with MRgFUS in a clinical trial at the University of Virginia.
Fibroid Relief has reached more than 85,000 women through its web site and Facebook group, has hosted events for hundreds of women around the U.S. and the U.K., and provided educational brochures to hundreds of domestic and international physicians at medical conferences.